8 Estate-Planning Documents You Need Right Now
11 Ways to Nail Savings on Your Remodeling Project
10 Fun, Creative Uses for Your Airline Miles
5 Times Suze Orman Didn't Follow Her Own Advice
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.